In the validation set the AUC was 0.82 (95% CI: 0.70–0.91; p < 0.0001) that confirms that the peptide marker model is highly significant for AKI leading to a sensitivity of 86% and a specificity of 76% at the predetermined cut‐off of –0.05 (Fig. 1 A).
← all excerpts
Development of a MALDI MS-based platform for early detection of acute kidney injury.
1
—
—